04:21 AM EST, 01/10/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) said late Thursday the UK Biobank Pharma Proteomics Project has chosen its Olink Explore Platform to support a human proteomics study.

Financial terms were not disclosed.

The project will analyze more than 5,400 proteins from 600,000 samples to help find new biomarkers that could potentially identify, diagnose and treat diseases, the company said.

The project is set to begin in Q1.